&w=3840&q=100)
New study finds repeated Covid-19 vaccines are safe for your metabolism
Researchers from Murdoch University in Australia conducted a 16-month-long study tracking how repeated Covid-19 vaccinations like the Pfizer-BioNTech and AstraZeneca vaccines affect the body — not just in terms of immune response, but also deeper changes in inflammation and metabolism. The study, titled Longitudinal study on immunologic, lipoproteomic, and inflammatory responses indicates the safety of sequential Covid-19 vaccination, was recently published in the J ournal of Molecular Medicine.
Their conclusion? No lasting side effects on the body's internal systems.
The researchers measured antibodies and checked over 130 health markers, including immune proteins (cytokines), cholesterol patterns, and small molecules in the blood. These tell us a lot about how the body is functioning behind the scenes.
They followed 33 healthy adults who received two to four doses of either the Pfizer-BioNTech or AstraZeneca vaccine. Blood samples were taken before and after each shot, and then followed up for over a year.
'The results showed no meaningful impact on key health indicators, including inflammatory markers, cardiovascular risk factors, and molecules involved in energy metabolism. Our findings provide insights into the safety of repeated Covid-19 vaccinations,' the study found.
Covid vaccine side effects show no link to long-term metabolic harm
While most participants reported mild side effects like a sore arm or feeling tired for a day or two, the researchers found no long-term changes in their metabolism. Even short-term fluctuations, like a temporary rise in a chemical called glutamic acid, returned to normal quickly.
Dr Subhashree Samantaray, Associate Consultant – Infectious Diseases at Manipal Hospitals, Bhubaneswar, clarifies, "The slight increase in glutamic acid after the third vaccine dose is not of medical concern. The study also tracked the glutamine to glutamate ratio — a more valid marker of metabolic stress — and found it holding steady. This balance indicates that the metabolic system kept everything well-regulated. These changes are routine and do not signal any long-term risks or dysfunction."
Interestingly, over 95 per cent of the samples from vaccinated people resembled those of completely healthy, uninfected individuals. Only a small fraction (5 per cent) resembled profiles seen in people with mild Covid-19 — mostly due to actual virus exposure, not the vaccine.
How repeated Covid vaccinations affect immune response and inflammation
A spike in a protein called IP10, which plays a role in immune responses, was seen briefly after the third shot. But this, too, was well within normal limits and quickly subsided.
Dr Samantaray explains why this isn't a concern, "A temporary elevation in cytokines such as IP10 is exactly what the body should be doing to fend off a first-encountered infection. It's a controlled, transient immune response that returned to baseline in a few days — well within the healthy range. There was no indication of prolonged inflammation or immune abnormalities."
Why long-term Covid vaccine safety studies still matter
Since the start of the SARS-CoV-2 pandemic, over 775 million cases and 7 million deaths have been recorded worldwide. While most patients have recovered, many face lasting effects. Since December 2020, over 13.6 billion Covid-19 vaccine doses have been administered. Vaccination has sharply reduced hospitalisations, deaths, and long Covid risk — though rare severe side effects such as inflammation of the brain and spinal cord (encephalomyelitis), and inflammation of the heart muscle (myocarditis), have emerged.
The withdrawal of the Oxford-AstraZeneca vaccine from the market highlights the need for continued research into the immunological, inflammatory, and metabolic effects of Covid-19 vaccines, both in the short and long term.
'Our findings show that repeated vaccination supports strong immunity without burdening the body's metabolic or inflammatory systems,' said the authors of the study.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


NDTV
2 hours ago
- NDTV
New COVID-19 Variant Spreading In US: All You Need To Know About XFG Variant
COVID-19 Cases In the US: The United States has lately seen an alarming rise in COVID-19 cases linked to a new variant, which has become the third-most common strain of the summer. The new XFG variant, colloquially known as "Stratus," is rapidly spreading across the US. This variant has also been found in many European countries. Variant XFG was first detected in Southeast Asia in January. According to a report by USA Today, the strain accounted for less than 0 per cent of cases in the US until May. But the cases saw a surge in June. The Centers for Disease Control and Prevention (CDC) revealed that the variant was estimated to account for up to 14 per cent of cases by late June. In the US, XFG accounted for 0% of cases through March. But it started to increase. In April, it reached 2%. It was 6% in late May, 11% in early June and 14% in late June. The CDC found that high or very high levels of cases are found in states like Alabama, Alaska, California, Delaware, Florida, Hawaii, Kentucky, Louisiana, and Texas. The cases are also rising in other states, including Connecticut, Georgia, Indiana, Maryland, Michigan, Minnesota, Mississippi, Missouri, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Utah, Virginia, Washington, and Wisconsin. Another starin, called NB.1.8.1 or Nimbus, is also a common variant in the US, as per the CDC. This variant leads to an extreme sore throat. What Do We Know About The XFG Variant According to the World Health Organization (WHO), XFG is a variant that is a recombinant of the lineages LF.7 and LP.8.1.2. The earliest sample was collected on 27 January 2025. In its June report, the WHO stated that XFG has been designated a variant under monitoring (VUM) with "increasing proportions globally". Experts have said that SARS-CoV-2, the virus that causes COVID-19, is constantly changing. It is accumulating mutations in its genetic code over time; hence, new variants are expected to continue to emerge. Subhash Verma, microbiology and immunology professor at the University of Nevada, Reno, told USA TODAY that the variant's mutations may enhance XFG's ability to evade immune responses. However, the world body has evaluated the additional public health risk posed by XFG as low at the global level, considering the available evidence. "There is currently no clear evidence that XFG causes more severe disease or significantly different symptoms than earlier Omicron variants," Verma said. "Importantly, there are no immediate public health concerns associated with this variant." WHO said that the currently approved COVID-19 vaccines are expected to remain effective against this variant against symptomatic and severe disease. What Are The Symptoms Of XFG? According to the CDC, the following are the common COVID-19 symptoms:


Hindustan Times
3 hours ago
- Hindustan Times
Cardiologist explains if 'Covid vaccines' contribute to increase in heart attacks: 'So much nonsense like mercury...'
'People have still not recovered' He shared his reservations in an August 6 Instagram video of his Impact Stories interview, in which he was asked about 'rumours' of increasing heart attacks being linked to the vaccines for Covid-19. Dr Chopra said in the post titled 'Why Covid vaccines are awful', 'So the thing is that the (Covid-19) vaccines came up suddenly. To make a vaccine can take a number of years; so to make a vaccine within months, obviously, it is not going to be the best. But they could not care less. That's the point... so the Covid vaccines have all sorts of nonsense put into them just to make them run quickly. That is why Covid came down on its own, but the aftermath became very bad. People died, people had so many issues, and people have still not recovered from it – and then came the variants, and they keep on doing it.' He added, 'The vaccine actually has so much nonsense like mercury and various other things. So obviously, the vaccine is going to go bad. In fact, I remember there was a big round table, I was in Las Vegas once, and they were talking about this and one guy was getting very nervous. The second vaccine which came... he blurted something that he should not be doing.' Want to make healthy-heart choices in life? Click here to know doctor-approved tips on how to keep cardiac problems at bay. Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.


Hans India
4 hours ago
- Hans India
Pulmonologists stress need for ‘Centre of excellence'
Tirupati: City MLA Arani Srinivasulu assured that he would take steps to establish a Centre for Excellence in Pulmonology at the Ruia Hospital. He was speaking at the inaugural session of APSACON 2025 (Association of Pulmonologists of Seema Andhra Conference), a national conference jointly organised by the Seemandhra Chest Physicians Association, the Department of Pulmonary Medicine at SV Medical College, and the Chest Physicians Forum, held at the Asha Convention Centre here on Saturday. The event drew participation from 150 leading pulmonologists and over 700 doctors from across the country. Experts delivered lectures and held group discussions with medical students on advanced treatment methods for asthma, tuberculosis, lung cancer, COPD, and pneumonia. A pre-conference workshop on Friday provided hands-on training in modern diagnostic techniques, including bronchoscopy and thoracoscopy. Addressing the gathering, MLA Srinivasulu noted that the government was taking steps to provide digital health cards to every family. Praising pulmonologists for their courage and service during the COVID-19 pandemic, he highlighted the growing prevalence of tuberculosis, allergies, and cancers due to changing lifestyles, stressing the need for proactive measures in prevention and diagnosis. Earlier, APSACON organising chariman Dr Premananda Raya and Head of the department of Pulmonology at SV Medical College Dr S Subba Rrao urged the MLA to support the setting up of the proposed Centre for Excellence in Pulmonology at Ruia Hospital. The MLA assured them that he would bring the matter to the Chief Minister's attention and work to ensure its establishment. NTR Health University Vice Chancellor Dr P Chandrasekhar, Scientific Committee member Dr Neeti Chandra, SVIMS Director Dr RV Kumar, Ruia hospital superintendent Dr J Radha, Principal of SV Medical College Dr G Ravi Prabhu, MLC Dr Cipai Subramanyam; AP State medical Council Chairman Dr D Sreeari Rao and others were present.